CELECOXIB Without Prescription For Acute Musculoskeletal Pain

CELECOXIB is now accessible without prescription for the short-term treatment of acute musculoskeletal pain. This presentation reviews the scientific evidence and clinical rationale for recommending CELECOXIB when considering a choice of non-steroidal anti-inflammatory drug (NSAID).

CELECOXIB (a selective NSAID) was first approved as a prescription only medicine in 1999 and has a well-established safety profile compared to traditional (non-selective) NSAIDs. This recording has been edited from a clinical session at the 2025 Australian Pharmacy Professional Conference.

Presenter

Joyce McSwan, Managing Director, PainWISE Pty Ltd

Host

Pain National Group

CPD Hours

0.5 Hour

Image: Hosein Sediqi on Unsplash